ArticleScientific reports2025
Prevalence and factors associated with metabolic syndrome and its components among overweight and obese reproductive-age women in Bac Giang, Vietnam.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Impact of metabolic comorbidities on the clinical course of West Nile virus infection.Journal of endocrinological investigation · 2026Article
- An Exploratory Study ofInternational journal of molecular sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Metabolic syndrome is more prevalent in women than in men in Vietnam, although data among women of reproductive age remain limited. A cross-sectional study was conducted in Bac Giang Province, Vietnam, in 2019 to estimate the prevalence of metabolic syndrome and its components, and to determine associations with sociodemographic and health factors in 194 overweight and obese women aged 20-45 years. Anthropometric indicators, plasma glucose and lipid concentrations, blood pressure, sociodemographic characteristics, medical status, medication/supplement use, and energy intake were measured. The prevalence of metabolic syndrome was 47.4% (95% CI: 40.5, 54.5%). Metabolic syndrome was significantly associated with obesity (OR: 4.14; 95% CI: 1.45, 11.85), and hypertension (OR: 25.40; 95% CI: 3.18, 202.89). Dyslipidemia, high plasma glucose concentrations, and hypertension were common. High parity was associated with higher plasma glucose and lower total cholesterol concentrations. Unemployment and higher plasma triglyceride concentrations were associated with higher total cholesterol concentrations. Increased systolic blood pressure and medical status were associated with higher triglyceride concentrations. Obesity was associated with high plasma glucose. These findings highlight the need for targeted interventions, including lifestyle modifications, routine clinical screening, and socioeconomic support for vulnerable groups, to prevent and manage metabolic syndrome in overweight and obese women of reproductive age.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.